Organization · Corporate Venture Capital
MSD Ventures
MSD Global Health Innovation Fund (MGHIF) is a corporate venture capital arm of MSD, focused on investing in digital health and data science companies to enhance biopharmaceutical operations and patient care.
Overview
What MSD Ventures does
What MSD Ventures is
MSD Global Health Innovation Fund (MGHIF) is a corporate venture capital arm of MSD, focused on investing in digital health and data science companies to enhance biopharmaceutical operations and patient care.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find MSD Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
MSD Ventures as a funder
Investment thesis
MGHIF invests in digital health and data-science companies whose technologies can improve patient care and optimize biopharmaceutical operations. The fund seeks platform companies with proven technologies or business models where MSD's resources can accelerate growth.
Focus narrative
MGHIF invests in digital health solutions across various sectors, including drug discovery, clinical development, manufacturing, supply chain, access to medicine, and real-world evidence generation. The fund typically invests in early-stage companies through accelerators, as well as in Series B and C rounds, with a global focus on North America and Europe.
Value beyond capital
MGHIF provides strategic support to portfolio companies by leveraging MSD's extensive healthcare expertise and resources. The fund aims to accelerate revenue growth and value creation for its partners through access to MSD's commercial and R&D capabilities.
Terms and economics
- Typical check
- $2,000,000–$10,000,000
Focus and fit
- Stages
- Accelerator · Seed · Series B · Series C · Growth Equity
- Sectors
- Digital Health
- Regions
- Global · North America · Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Zapata Quantum
Portfolio context
Notable portfolio companies include: AeroSafe Global: Provides cold-chain services for the biopharma industry. Aitia: A causal AI company focused on drug response. Arcadia Healthcare Solutions: Offers population health and analytics technology. Ash Wellness: Provides at-home diagnostic testing solutions. Atropos Health: Delivers on-demand evidence from real-world data. Baseimmune: Develops mutation-resistant vaccines using AI. Bighat: Designs antibody therapies using machine learning. Delfi Diagnostics: Analyzes cell-free DNA using machine learning. Emerald Cloud Labs: A remote-controlled life science laboratory. Evaxion: Develops AI-powered vaccines. PathAI: Assists pathologists with diagnostic technology. Qure AI: Provides AI-powered healthcare reporting. Transcarent: A consumer-directed health platform for self-insured employers.
Common questions
What to know about MSD Ventures
Upseed classifies MSD Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.